Obesity and the metabolic syndrome in patients with acute myocardial infarction

Prasad, S.; Fahrtash, Farzan; Malaiapan, Yuvaraj; Meredith, Ian T.; Cameron, James D.

doi:10.1016/j.ijcard.2009.03.089

Cited by 16 publications

(16 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, it extends the observations of Zeller and colleagues 3 of higher female and lower smoking prevalence among MetS patients. Our study, based on an unselected large population of ACS patients in the Middle East reports the highest prevalence of diabetes mellitus (40%) when compared with previous reports, which ranged from 19% (in Australia) 8 to 34% (in Japan) 9 . In a post hoc analysis of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI‐Prevenzione) trial, which included 10,384 patients who had recent MI (within 3 months), Levantesi and colleagues 13 reported a 29.3% and 21% prevalence of MetS and diabetes mellitus, respectively.…”

Section: Discussioncontrasting

confidence: 41%

“…Few studies reported the prevalence of MetS, as defined by the NCEP‐ATP III, NHLBI/AHA, and/or IDF criteria in patients with ACS, 2–15 (Table III), which were mostly registry data conducted in North America, Europe, Japan, and Australia and included a small number of patients (107–633 patients) with an MetS prevalence ranging from 20.8% to 79.1%. Our study confirms this high prevalence of MetS (46%) using the new MetS definition in a larger unselected population (6701 patients).…”

Section: Discussionmentioning

confidence: 99%

“…MetS represents a constellation of cardiovascular risk factors, including elevated blood pressure (BP), hyperglycemia, elevated triglyceride levels, central obesity, and decreased high‐density lipoprotein cholesterol 1 . The prevalence of MetS among patients with acute coronary syndrome (ACS) is limited by small registries and post hoc analyses of randomized trials that use three different guideline definitions for MetS (Third Report of the Adult Treatment Panel National Cholesterol Education Program [NCEP‐ATP III] definition; National Heart, Lung and Blood Institute/American Heart Association [NHLBI/AHA] definition; and International Diabetes Federation [IDF] definition), making consensus about their findings difficult 2–15 . More recently, a joint statement of the IDF Task Force on Epidemiology and Prevention, NHLBI, AHA, the World Heart Federation, the International Atherosclerosis Society, and the International Association for the Study of Obesity unified the diagnostic criteria of MetS 16 .…”

mentioning

confidence: 99%

See 2 more Smart Citations

Prevalence of the Metabolic Syndrome in Patients With Acute Coronary Syndrome in Six Middle Eastern Countries

Suwaidi

Zubaid

El‐Menyar

et al. 2010

J of Clinical Hypertension

View full text Add to dashboard Cite

J Clin Hypertens (Greenwich). The objective of this study was to evaluate the prevalence and effect of the metabolic syndrome (MetS) on patients with acute coronary syndrome (ACS) in six Middle Eastern countries using the new definition of MetS. Analysis of the Gulf Registry of Acute Coronary Events (Gulf RACE), which included 8716 consecutive patients hospitalized with ACS, was conducted and patients were divided into two groups: patients with and patients without the MetS. Overall, 46% of patients had MetS. Patients with MetS were more likely to be female and less likely to be smokers. In‐hospital mortality and cardiogenic shock were comparable between the two groups, although MetS patients were more likely to have congestive heart failure and recurrent ischemia. In ST‐elevation myocardial infarction, MetS was also associated with increased risk of recurrent myocardial infarction and stroke. Using the recent MetS definition, MetS is highly prevalent among Middle Eastern patients presenting with ACS. MetS is associated with higher‐risk profile characteristics and increased risk for development of heart failure and recurrent myocardial ischemia without an increase in hospital mortality. J Clin Hypertens (Greenwich). 2010;12:890–899.

show abstract

Section: Discussioncontrasting

confidence: 41%

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of the Metabolic Syndrome in Patients With Acute Coronary Syndrome in Six Middle Eastern Countries

Suwaidi

Zubaid

El‐Menyar

et al. 2010

J of Clinical Hypertension

View full text Add to dashboard Cite

show abstract

“…In addition, medications as nitrates and beta‐blockers negatively modulate blood pressure and statin administration affects lipid profile. To overcome these problems, the lipid profile was investigated in the morning after admission, while plasma glucose, AST, ALT and GGT were measured at discharge . We cannot rule out the possibility that the normal levels of transaminases found in our patients could be due almost in part to the subacute phase during which patients with STEMI had been investigated.…”

Section: Discussionmentioning

confidence: 95%

Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes

Boddi

Tarquini

Chiostri

et al. 2013

Eur J Clin Investigation

View full text Add to dashboard Cite

show abstract

“…Although it is well known that the incidence of MetS during acute myocardial infarction is high and that it predisposes to higher rate of complications [21], MetS is, however, still under-diagnosed and under-treated [41]. Recognizing MetS in patients during ACS as of very high risk for larger infarction size and heart failure rate (especially in females) leads us to pay more attention to this group of patients, during hospitalization as well on discharge.…”

Section: Resultsmentioning

confidence: 99%